Group items tagged

Drug-Related Deafnss Gene Mutations Detection

Epilepsy-related Gene Detection The Epilepsy-related gene testing of CapitalBio Technology is based on BES4000 semi-conductor sequencing platform, using target region capture and NGS technology together to detect the genes related epilepsy.

Fetal Chromosomal Aneuploidies and Microdeletions/ Microduplications Detection (NIPT-Plus) Fetal Chromosomal Aneuploidies and Microdeletions/ Microduplications Detection (NIPT-Plus) can find 100 chromosomal diseases at once, including 3 common chromosomal aneuploidies, 4 sex chromosomal aneuploidies, and 93 microdeletion duplication syndromes.

GJB2 Gene Coding Region and Splicing Site Detection This test is based on NGS technology, by detecting SNV、small InDel (<20bp) of GJB2 exon and 10bp intron of its upstream and downstream, can provide information as if the subject carrying GJB2 gene related deafness mutations.

Human Papillomavirus (HPV) Genotyping Detection HPV is a virus that causes cancer and can be further subdivided into high-risk and low-risk types. Cervical cancer can only result from persistent infection with high-risk HPV. Cervical cancer is the only form of cancer that can be prevented and cured if caught at an early stage due to a known and treatable cause. When it comes to reducing the incidence and mortality rates associated with cervical cancer, HPV screening is the most effective and direct method of prevention, detection, diagnosis, and treatment.

Hereditary Deafness Gene Detection (227 Genes+Mitochondrial Genome) This test is based on NGS technology, it can detect 227 nuclear genomes + mitochondrial genome sequence, covering reported non-syndromic deafness and syndrome deafness.

CapitalBio Technology Co., Ltd. (abbreviated "CapitalBio") is the industrialization platform of the CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips.

Trisomy 21 (Down syndrome), trisomy 18 (Edward's syndrome), and trisomy 13 (Patau's syndrome) are the three most prevalent autosomal aneuploid diseases. The incidence in newborns is 1/(600-800), 1/(3500-8000), and 1/(7000-20000). Intellectual disability, developmental delay, multiple deformities, reproductive disorders, etc. are common in children. Using a fetal chromosome aneuploidy (T21, T18, T13) detection kit (semiconductor sequencing), doctors can reliably identify these conditions in unborn children (trisomy 21, trisomy 18, and trisomy 13).

Fetal Aneuploidies (Trisomy 21, Trisomy 18 and Trisomy 13) Detection IVD Medical Device | Capitalbio

The Disease Susceptibility Genetic Test-Cardiovascular Disease (14 Items) IVD Medical Device | Capitalbio

Folic Acid Utilization Ability Genetic Detection Folic acid is mainly involved in nucleic acid, protein synthesis and DNA methylation in the human body, and is an essential micronutrient for the human body. The human body cannot synthesize folic acid on its own and must obtain it from food. But some people develop folic acid deficiencies even when they maintain a normal intake of folic acid.

According to research reports, individuals with inherited cancer genes have a higher risk of cancer than ordinary people. About 7% of breast cancer and 1%-15% of ovarian cancer are caused by BRCA1/BRCA2 gene mutations. In families with a high incidence of breast and ovarian cancer, 80% of patients have mutations in the BRCA1/BRCA2 gene, and this gene is inherited in an autosomal dominant manner in the population. This test detects the entire coding region of BRCA1/BRCA2 genes, and 20bp intron regions upstream and downstream of the coding region, in addition to known mutation hotspot genes, unknown mutations can be detected.

Human Mitochondrial Genome Detection Mitochondrial diseases refer to a group of multi-system diseases caused by dysfunction of mitochondrial respiratory chain leading to ATP synthesis disorder, can affect muscles, central nervous system, kidneys, cardiovascular, eye, ear, digestive, endocrine, cardiovascular and renal systems individually or simultaneously. It can occur in any part of the body or at any age, the incidence is about 1/8500. For this test, CapitalBio use two long-segment PCR amplification and high-throughput sequencing technologies to analyze the full length of the entire mitochondrial gene (16569bp), the latest Cambridge version of the mitochondrial genome NC_012920 was used as a reference for comparison and analysis.

Glass Bottom Cell Culture Dish TC-Treated TC-treated square cell culture dish for cell and biological tissue cultivation, as well as bacterium detection. Furthermore, the absorbent pad nature of the TC treated culture plate makes it excellent for microbiological identification and detection.

T120H Fever Screening Thermal Camera is a fast temperature detection tool, which can be used to detect human temperature from a safety distance with accuracy of ±0.5℃. It is an economical and practical thermal camera that could meet the needs of primary temperature screening well. With two intelligent temperature screening modes, GUIDE T120H is not only suitable for flexible temperature screening, but also can be deployed at the entrances and exits of the public area, which makes it an ideal device to improve the efficiency of epidemic prevention and protect public health.

CMA Chips, CMA Detection for IVD Medical Device | Capitalbio

The professional skin analysis machine is a state-of-the-art skin analysis device that helps professionals and individuals get an in-depth understanding of their skin health. The device adopts RGB and UV light sources through spectral imaging technology, which enables it to detect eight skin problems that are present on both surface and deep skin layers. Non-Invasive Skin Analysis Machine Detailed Description The 3D facial skin analyzer machine is a state-of-the-art skin analysis device that helps professionals and individuals get an in-depth understanding of their skin health. The device adopts RGB and UV light sources through spectral imaging technology, which enables it to detect eight skin problems that are present on both surface and deep skin layers.

Genetic Testing for BRCA1/2 Targeted-drug Guidance [ Germline + Somatic] This test detects somatic and germline SNV, InDel and CNV mutations in the BRCA1 and BRCA2 genes, covering the entire coding region of the BRCA1/2 gene and both flanking intron regions, provide information to guide PARP inhibitor therapy in breast & ovarian cancer.

Forensic Platform Forensic DNA identification is a scientific and technological weapon for investigation and litigation. The inspection includes DNA extraction, PCR amplification, electrophoresis detection, and other links, which require professionals to operate different instruments in the laboratory for 6-8 hours. Based on microfluidic technology, capialbio developed the first Rapid DNA test system in China in 2012.

Genetic Testing for Blood Cancer This test can detect SNV, Indel, and FLT3-ITD information of 232 genes associated with blood cancers, covers all types of leukemia - AML/ALL/CML/CLL/MDS/MPN and various lymphomas.

Genetic Testing of 18 Hereditary Cancer This test can provide risk assessment in high-risk groups with a family history by detecting gene mutations in the entire coding region and splice region of 64 genes associated with 18 hereditary tumors at one time.